BBOT: Funding, Investors & Team (Sep 2026)
BBOT is a biopharmaceutical company in the clinical stage that is developing a new pipeline of small molecule drugs to treat cancers caused by RAS and PI3Kα mutations. The company aims to enhance the survival rates of patients with these types of cancer, which are driven by the most common oncogenes in human tumors. Visit bridgebiooncology.com for further details.
BBOT has raised $261M across 1 funding round on record, the most recent an undisclosed round of $261M announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BBOT Company Profile and Key Stats
Latest funding round on record: Aug 2025.
BBOT Funding Rounds
BBOT Founders and Leadership Team
Contact details for the BBOT team: 1 of 1 has an email address on file.
Start 14-day free trial →BBOT Funding Compared to Other Biotechnology Startups
BBOT's latest round of $261M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BBOT in Biotechnology and Palo Alto
Companies Similar to BBOT
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
BBOT Funding FAQs
What does BBOT do?
BBOT is a biopharmaceutical company in the clinical stage that is developing a new pipeline of small molecule drugs to treat cancers caused by RAS and PI3Kα mutations. The company aims to enhance the survival rates of patients with these types of cancer, which are driven by the most common oncogenes in human tumors. Visit bridgebiooncology.com for further details.
How much funding has BBOT raised?
BBOT has raised $261M across 1 round on record. The most recent is an undisclosed round of $261M announced in Aug 2025.
When did BBOT last raise funding?
BBOT's most recent funding round on record is an undisclosed round of $261M, announced in Aug 2025.
Who founded BBOT?
FundedIQ lists Eli M Wallace (Founder) at BBOT.
Where is BBOT headquartered?
BBOT is based in Palo Alto, California, United States.
How many employees does BBOT have?
BBOT is in the 51-100 employee band.
How does BBOT's funding compare to other Biotechnology startups?
BBOT's latest round of $261M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's BBOT Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BBOT is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.